Spineology released the Elite™ Expandable Interbody Fusion system, designed to be implanted at a minimal height and expanded after final positioning in the disc space.
OrthoPediatrics filed to raise up to US $75MM in an initial public offering. The company plans to list on the NASDAQ under the symbol KIDS. Pricing terms were not disclosed.
Zimmer Biomet commenced global launch of enhancements to its OSS™ Orthopedic Salvage joint reconstruction prostheses, designed to treat bone loss due to trama, tumor, multiple revision arthroplasties, etc.
Tyber Medical received FDA 510(k) clearance of its headed and snap-off screws with configurations incorporating the proprietary BioTy™ modified surface treatment.
Strategic orthopaedic-related 510(k)s issued in May 2016 include: Navio Indication for TKA (Blue Belt Technologies), Enza Zero-profile Anterior Interbody Fusion System (Camber Spine), CSR Shoulder System (Catalyst OrthoScience*), Stropp/Single Tunnel Repair of Plantar Plate (CrossRoads Extremity), Cervical Interbody Fusion System (Evolution Spine*), Flip Button Suture Anchor (First Ray), Neofuse HA Enhanced PLIF/TLIF (HT Medical*), HC Spinal System (Hung Chun Bio-S*)
Bone Biologics signed an option agreement with UCLA for an opportunity to exclusively license the use of Nell-1 bone growth factor in the treatment of osteoporosis.